Long-Term Treatment with 300IR 5-Grass Pollen Sublingual Tablet in Grass Pollen Allergic Subjects: Safety Outcome Year after Year

被引：0
|
作者：
Golden, David B. K. [1 ]
Fahrenholz, John M. [2 ]
Renahan, Kevin E. [3 ]
Khairallah, Sandrine [4 ]
Abiteboul, Kathy [4 ]
机构：
[1] Medstar Franklin Sq Med Ctr, Baltimore, MD USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Stallergenes Greer, Cambridge, MA USA
[4] Stallergenes Greer, Antony, France
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.148
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
191
引用
收藏
页码：AB60 / AB60
页数：1
相关论文
共 50 条
  • [21] Efficacy And Safety Of Sublingual 300IR 5-grass Pollen Tablets In Adult Patients With Grass-pollen Rhinoconjunctivitis In United States
    Cox, L.
    Casale, T.
    Nayak, A.
    Bernstein, D.
    Mekhaldi, S.
    De Beaumont, O.
    Melac, M.
    Montagut, A.
    Creticos, P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB74 - AB74
  • [22] Impact of treatment with 300IR five-grass pollen sublingual tablet on quality of life in grass pollen allergic US adults
    Cox, L.
    Bernstein, D.
    Nayak, A.
    Montagut, A.
    Abiteboul, K.
    Zeldin, R.
    ALLERGY, 2012, 67 : 418 - 419
  • [23] PEDIATRIC OBSERVATIONAL STUDY OF 300IR 5-GRASS TABLET IN GRASS POLLEN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS: FURTHER SAFETY DATA
    Geng, B.
    Gerstlauer, M.
    Szepfalusi, Z.
    de Bilc, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S30 - S30
  • [24] Real life safety experience with 5-grass pollen sublingual tablet for the treatment of grass pollen-induced allergic rhinoconjunctivitis
    Didier, A.
    Bons, B.
    Zeldin, R. K.
    ALLERGY, 2015, 70 : 114 - 114
  • [25] Long-term clinical efficacy of a 5-grass pollen sublingual immunotherapy tablet in adults with grass pollen-induced allergic rhinoconjunctivitis
    Didier, A.
    Horak, F.
    Worm, M.
    Melac, M.
    de Beaumont, O.
    Montagut, A.
    Galvain, S.
    Rodriguez, P.
    Malling, H.
    ALLERGY, 2011, 66 : 654 - 654
  • [26] Relationship between disease severity and post-treatment, long-term efficacy of 300IR 5-grass pollen sublingual tablets
    Didier, A.
    Malling, H.
    Worm, M.
    Amistani, Y.
    Le Gall, M.
    Zeldin, R.
    ALLERGY, 2012, 67 : 135 - 135
  • [27] Efficacy and safety of 300IR 5-grass pollen sublingual allergen immunotherapy tablets in adult patients with grass-pollen rhinoconjunctivitis in United States
    Cox, L.
    Casale, T.
    Nayak, A.
    Bernstein, D.
    Mekhaldi, S.
    de Beaumont, O.
    Melac, M.
    Montagut, A.
    Creticos, P.
    ALLERGY, 2011, 66 : 63 - 63
  • [28] Treatment effect of 300IR 5-grass pollen tablet for pre-coseasonal sublingual immunotherapy of grass pollen-induced allergic rhinoconjunctivitis: Clinical impact from the patient perspective
    Brehler, R.
    Pfaar, O.
    Canonica, G. W.
    Devillier, P.
    Demoly, P.
    Scurati, S.
    Dolimier, E.
    ALLERGY, 2023, 78
  • [29] Consistency Of Clinical Results Throughout Short-term And Long-term Studies With Sublingual 300IR 5-grass Pollen Tablets
    Bachert, C.
    Didier, A.
    Wahn, H.
    Le Gall, M.
    De Beaumont, O.
    Melac, M.
    Montagut, A.
    Malling, H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB49 - AB49
  • [30] An assessment of sustained efficacy and safety of a 300IR five-grass pollen sublingual immunotherapy tablet in adults with grass pollen induced allergic rhinoconjunctivitis during a 3-year treatment study
    Didier, A.
    Horak, F.
    Worm, M.
    Melac, M.
    de Beaumont, O.
    Le Gall, M.
    Montagut, A.
    Galvain, S.
    Malling, H.
    ALLERGY, 2010, 65 : 172 - 172
12345